These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12569241)

  • 1. All hats off to ALLHAT: a massive study with clear messages.
    Chalmers J
    J Hypertens; 2003 Feb; 21(2):225-8. PubMed ID: 12569241
    [No Abstract]   [Full Text] [Related]  

  • 2. The meaning of ALLHAT.
    Kaplan NM
    J Hypertens; 2003 Feb; 21(2):233-4. PubMed ID: 12569243
    [No Abstract]   [Full Text] [Related]  

  • 3. The ALLHAT trial: strengths and limitations.
    Fagard RH
    J Hypertens; 2003 Feb; 21(2):229-32. PubMed ID: 12569242
    [No Abstract]   [Full Text] [Related]  

  • 4. ALLHAT and beyond.
    Alderman MH
    Am J Hypertens; 2003 Jun; 16(6):512-4. PubMed ID: 12799104
    [No Abstract]   [Full Text] [Related]  

  • 5. The ALLHAT trial: a verdict or a challenge?
    Zanchetti A; Mancia G
    J Hypertens; 2003 Feb; 21(2):223. PubMed ID: 12569240
    [No Abstract]   [Full Text] [Related]  

  • 6. Comments on the renal aspects of the ALLHAT study.
    Ruilope LM
    J Hypertens; 2003 Feb; 21(2):235-6. PubMed ID: 12569244
    [No Abstract]   [Full Text] [Related]  

  • 7. The ALLHAT and the cardioprotection conferred by diuretics in hypertensive patients: a connection with uric acid?
    Reyes AJ; Leary WP
    Cardiovasc Drugs Ther; 2002 Dec; 16(6):485-7. PubMed ID: 12797357
    [No Abstract]   [Full Text] [Related]  

  • 8. A specialist in clinical hypertension critiques ALLHAT.
    Meltzer JI
    Am J Hypertens; 2003 May; 16(5 Pt 1):416-20. PubMed ID: 12745205
    [No Abstract]   [Full Text] [Related]  

  • 9. ALLHAT: a critical assessment.
    Sjöholm A
    Blood Press; 2004; 13(2):75-9. PubMed ID: 15182109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALLHAT and ANBP2: what have we learned from recent mega-trials?
    Sander GE; Giles TD
    Am J Geriatr Cardiol; 2003; 12(4):267-71. PubMed ID: 12888711
    [No Abstract]   [Full Text] [Related]  

  • 11. [What did the ALLHAT study bring? To do the one without foregoing the other].
    MMW Fortschr Med; 2003 Dec; 145(51-52):36-7. PubMed ID: 14974327
    [No Abstract]   [Full Text] [Related]  

  • 12. ALLHAT and AFFIRM.
    Liebson PR
    Prev Cardiol; 2003; 6(1):54-60. PubMed ID: 12624564
    [No Abstract]   [Full Text] [Related]  

  • 13. LIFE and SCOPE: what guidance do they offer alongside ALLHAT and ANBP2?
    Nicholls MG
    J Hum Hypertens; 2004 May; 18(5):295-300. PubMed ID: 14739907
    [No Abstract]   [Full Text] [Related]  

  • 14. ALLHAT--all hit or all miss? Key questions still remain.
    Messerli FH; Weber MA
    Am J Cardiol; 2003 Aug; 92(3):280-1. PubMed ID: 12888131
    [No Abstract]   [Full Text] [Related]  

  • 15. The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohort.
    Hebert LA; Rovin BH; Hebert CJ
    Nat Clin Pract Nephrol; 2007 Feb; 3(2):60-1. PubMed ID: 17251990
    [No Abstract]   [Full Text] [Related]  

  • 16. Guidelines for antihypertensive treatment: an update after the ALLHAT study.
    Salvetti A; Ghiadoni L
    J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S51-4. PubMed ID: 14684673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience.
    Wright JT; Cushman WC; Davis BR; Barzilay J; Colon P; Egan D; Lucente T; Nwachuku C; Pressel S; Leenen FH; Frolkis J; Letterer R; Walsh S; Tobin JN; Deger GE;
    Control Clin Trials; 2001 Dec; 22(6):659-73. PubMed ID: 11738122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT.
    Laragh JH; Sealey JE
    Am J Hypertens; 2003 May; 16(5 Pt 1):407-15. PubMed ID: 12745204
    [No Abstract]   [Full Text] [Related]  

  • 19. The ALLHAT-LLT and ASCOT-LLA trials: are the discrepancies more apparent than real?
    Hennekens CH
    Curr Atheroscler Rep; 2004 Jan; 6(1):9-11. PubMed ID: 14662102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): practical implications.
    Oparil S
    Hypertension; 2003 May; 41(5):1006-9. PubMed ID: 12695423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.